Pharmaceutical compositions comprising heparinoids and methods for preparing thereof
AssigneeHarrow IP, LLC
InventorDennis Elias Saadeh
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions are described herein, among others, the compositions comprising anhydrous suspensions of a therapeutically effective quantity of a heparinoid, or a derivative or analog thereof, and to methods of preparing and using such compositions. The use of various heparinoids for these purposes is disclosed, such as pentosan, heparin, hyaluronic acid, chondroitin, and pharmaceutically acceptable salts thereof. Methods for fabricating the compositions and using them are also described.
Claims29
A pharmaceutical composition formulated as an anhydrous suspension comprising:
- (a) a dispersed phase comprising a therapeutically effective quantity of a pharmaceutically acceptable heparinoid;
- and
- (b) an anhydrous dispersion medium optionally comprising at least one pharmaceutically acceptable surfactant, solubilizing agent, and/or suspending agent,
- wherein the dispersed phase is dispersed within the dispersion medium.
A pharmaceutical composition comprising a therapeutically effective quantity of a pharmaceutically acceptable heparinoid and an excipient that enables delayed release or sustained release of the heparinoid.
A method for treating, preventing or alleviating osteoarthritis comprising administering to the patient by an injection an aqueous composition comprising a therapeutically effective quantity of a pharmaceutically acceptable heparinoid, wherein the injection is selected from the group consisting of an intravenous injection, intramuscular injection and intraarticular injection.
A pharmaceutical composition formulated as an anhydrous suspension comprising:
- (a) a dispersed phase comprising a therapeutically effective quantity of a pharmaceutically acceptable heparinoid;
- and
- (b) an anhydrous dispersion medium;
- wherein the concentration of heparinoid in the suspension does not deviate by more than ±10%, after storage at room temperature for at least 30 days.
Dependencies are inferred from the claim text.